Christopher W. Ryan

9.7k citations
165 papers · 6.0k · 3 hit papers · h-index 38

Impact in

    • Gastrointestinal Tumor Research and Treatment
    • Renal cell carcinoma treatment
    • Sarcoma Diagnosis and Treatment
    • Prostate Cancer Treatment and Research
    • Gastric Cancer Management and Outcomes

Papers in

Christopher W. Ryan

160 papers receiving 5.9k citations

Christopher W. Ryan's Hit Papers

Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial 2016 · 317 citations
3170+6+12Years since publication250500750

Peers

Christopher W. Ryan
Comparison fields: 5 of 125
  • Gastroenterology 1.2k
  • Pulmonary and Respiratory Medicine 3.0k
  • Oncology 1.4k
  • Cancer Research 714
  • Pathology and Forensic Medicine 419
Replace Annalisa Astolfi with:
Annalisa Astolfi Italy
Maria A. Pantaleo Italy
Kiyokazu Nakajima Japan
Angela Greco Italy
Janusz Ryś Poland
Hidetaka Yamamoto Japan
Paul M. Schneider Germany
Tadakazu Shimoda Japan
Claus Langer Germany
Marvin M. Romsdahl United States
Christopher W. Ryan relative to Annalisa Astolfi Italy Annalisa Astolfi's profile →
Citations per field
00.5×1.5×2.2×
Annalisa Astolfi · 1×
Citations per year

Countries citing papers authored by Christopher W. Ryan

Since Specialization
Citations

This map shows the geographic impact of Christopher W. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher W. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher W. Ryan more than expected).

Fields of papers citing papers by Christopher W. Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher W. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher W. Ryan. The network helps show where Christopher W. Ryan may publish in the future.

Co-authors

The 25 scholars most cited alongside Christopher W. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Christopher W. Ryan Line = papers co-authored together Christopher W. Ryan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 165 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033
Hit paper breakdown →
2008775
2
Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group
Hit paper breakdown →
2008439
3
Everolimus versus sunitinib for patients with metastatic non-clear cell renal cell carcinoma (ASPEN): a multicentre, open-label, randomised phase 2 trial
Hit paper breakdown →
2016317
4 2007235
5 2010194
6 2019182
7 2014169
8 2011142
9 2007117
10 2003114
11 2006107
12 200896
13 199894
14 200594
15 200393
16 201191
17 201489
18 200785
19 201482
20 202180

About Christopher W. Ryan

Christopher W. Ryan is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Ecology, having authored 165 papers that have together received 6.0k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (33 papers), Sarcoma Diagnosis and Treatment (23 papers), Prostate Cancer Treatment and Research (15 papers), Cancer Genomics and Diagnostics (15 papers), Wildlife Ecology and Conservation (11 papers), Renal and related cancers (9 papers), Gastrointestinal Tumor Research and Treatment (8 papers) and Cancer Immunotherapy and Biomarkers (7 papers). The work is most often cited by research in Gastroenterology (1.2k citations), Pulmonary and Respiratory Medicine (3.0k citations), Oncology (1.4k citations), Cancer Research (714 citations) and Pathology and Forensic Medicine (419 citations). Christopher W. Ryan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Tomasz M. Beer, George D. Demetri, Margaret von Mehren, Ernest C. Borden, Cathryn Rankin, Charles D. Blanke, Vivien Bramwell, Walter M. Stadler, Michael C. Heinrich and Robert S. Benjamin. Their work appears in journals such as Journal of Clinical Oncology, Cancer, The Journal of Urology, Clinical Cancer Research and Ursus.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact